Cargando…
Proteomic biomarkers in body fluids associated with pancreatic cancer
Pancreatic cancer (PC) is a highly malignant disease that represents the fourth leading cancer-related death worldwide. There has been very little improvement in survival rates over recent years, and surgical resection remains the only reliable curative approach. Factors that contribute to this dism...
Autores principales: | Jimenez-Luna, Cristina, Torres, Carolina, Ortiz, Raul, Dieguez, Carmelo, Martinez-Galan, Joaquina, Melguizo, Consolacion, Prados, Jose C., Caba, Octavio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893263/ https://www.ncbi.nlm.nih.gov/pubmed/29662668 http://dx.doi.org/10.18632/oncotarget.24654 |
Ejemplares similares
-
Serum biomarkers for the differentiation of autoimmune pancreatitis from pancreatic ductal adenocarcinoma
por: Caba, Octavio, et al.
Publicado: (2023) -
Discovery of Pancreatic Adenocarcinoma Biomarkers by Untargeted Metabolomics
por: Martín-Blázquez, Ariadna, et al.
Publicado: (2020) -
Role of Exocrine and Endocrine Insufficiency in the Management of Patients with Chronic Pancreatitis
por: Diéguez-Castillo, Carmelo, et al.
Publicado: (2020) -
Liquid biopsy approach to pancreatic cancer
por: Perales, Sonia, et al.
Publicado: (2021) -
State of the Art in Exocrine Pancreatic Insufficiency
por: Diéguez-Castillo, Carmelo, et al.
Publicado: (2020)